EGFR and neoplasm: Likewise, SKLB261 (multikinase inhibitor of EGFR, SRC, and VEGFR2) potently suppressed the proliferation and invasion of human PDAC cells, restored chemo-sensitivity, and extended the survival of tumor-bearing mice [202].